We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+10.55%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$3.14B
AUM Growth
+$728M
Cap. Flow
+$534M
Cap. Flow %
17.01%
Top 10 Hldgs %
37.86%
Holding
6,828
New
511
Increased
3,030
Reduced
2,253
Closed
625

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$204M
2
TSM icon
TSMC
TSM
+$94.9M
3
QQQ icon
Invesco QQQ Trust
QQQ
+$58M
4
IWO icon
iShares Russell 2000 Growth ETF
IWO
+$23M
5
VNQ icon
Vanguard Real Estate ETF
VNQ
+$17.9M

Top Sells

Rank Stock Value
1
IWM icon
iShares Russell 2000 ETF
IWM
+$52.8M
2
AAPL icon
Apple
AAPL
+$32.5M
3
MSFT icon
Microsoft
MSFT
+$16.2M
4
XLE icon
State Street Energy Select Sector SPDR ETF
XLE
+$14.5M
5
DIS icon
Walt Disney
DIS
+$14.2M

Sector Composition

Rank Sector Weight
1 Technology 21.21%
2 Consumer Discretionary 7.37%
3 Financials 6.36%
4 Healthcare 5.92%
5 Industrials 5.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BCPC
1726
Balchem Corp
BCPC
$5.71B
$117K ﹤0.01%
926
+635
+218% +$82.1K
BCO icon
1727
Brink's
BCO
$4.69B
$116K ﹤0.01%
1,733
-260
-13% -$16.5K
DGRW icon
1728
WisdomTree Trust WisdomTree US Quality Dividend Growth Fund
DGRW
$17.3B
$116K ﹤0.01%
1,854
+1,303
+236% +$80.1K
GOSS icon
1729
Gossamer Bio
GOSS
$88.9M
$116K ﹤0.01%
92,436
+23,548
+34% +$45.1K
HCM icon
1730
HUTCHMED
HCM
$2.17B
$116K ﹤0.01%
8,931
+1,855
+26% +$30.4K
HP icon
1731
Helmerich & Payne
HP
$4.25B
$116K ﹤0.01%
3,269
-2,937
-47% -$127K
NGVT icon
1732
Ingevity
NGVT
$2.67B
$116K ﹤0.01%
1,621
+607
+60% +$48.2K
PINE
1733
Alpine Income Property Trust
PINE
$346M
$116K ﹤0.01%
6,884
+6,269
+1,019% +$116K
KDNY
1734
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$116K ﹤0.01%
5,029
+4,001
+389% +$95.4K
AAON icon
1735
Aaon
AAON
$7.03B
$115K ﹤0.01%
1,785
+1,381
+342% +$75.9K
CIG icon
1736
CEMIG Preferred Shares
CIG
$5.64B
$115K ﹤0.01%
66,788
+49,580
+288% +$79.1K
IDYA icon
1737
IDEAYA Biosciences
IDYA
$3.55B
$115K ﹤0.01%
8,343
+5,455
+189% +$90.9K
OI icon
1738
O-I Glass
OI
$1.1B
$115K ﹤0.01%
5,055
+4,523
+850% +$94.9K
REPL icon
1739
Replimune Group
REPL
$1.15B
$115K ﹤0.01%
6,493
+3,877
+148% +$92.2K
SR icon
1740
Spire
SR
$4.87B
$115K ﹤0.01%
1,647
-7,372
-82% -$523K
ITCI
1741
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$115K ﹤0.01%
2,121
+1,260
+146% +$60.9K
AXGN icon
1742
Axogen
AXGN
$2.61B
$114K ﹤0.01%
12,040
+1,828
+18% +$16.7K
BKLN icon
1743
Invesco Senior Loan ETF
BKLN
$6.75B
$114K ﹤0.01%
5,478
+579
+12% +$12.1K
DMC
1744
Del Monte Corp
DMC
$1.45B
$114K ﹤0.01%
3,790
-13,921
-79% -$404K
IBOC icon
1745
International Bancshares
IBOC
$4.48B
$114K ﹤0.01%
2,657
-1,885
-42% -$85.7K
RVLV icon
1746
Revolve Group
RVLV
$1.69B
$114K ﹤0.01%
4,309
+1,223
+40% +$31.6K
STAA icon
1747
STAAR Surgical
STAA
$1.24B
$114K ﹤0.01%
1,774
-8,597
-83% -$561K
TTD icon
1748
Trade Desk
TTD
$6.37B
$114K ﹤0.01%
1,870
-16,245
-90% -$865K
WPM icon
1749
Wheaton Precious Metals
WPM
$61B
$114K ﹤0.01%
2,361
+2,237
+1,804% +$97.8K
SLGC
1750
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
$114K ﹤0.01%
44,816
+40,949
+1,059% +$117K
68 69
70
71 72

Similar funds

CA
CSM Advisors Warrendale, Pennsylvania $4.07B AUM 29.62% 1-Year Est. Return
BHC
Bowen Hanes & Co Ponte Vedra Beach, Florida $4.11B AUM 41.61% 1-Year Est. Return
ICP
Ilex Capital Partners London, United Kingdom $4.06B AUM 6.11% 1-Year Est. Return
AP
Altarock Partners West Palm Beach, Florida $4.13B AUM 0.04% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
BOK
Bank of Korea Seoul, South Korea $4.13B AUM
JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
SP
Stockbridge Partners Boston, Massachusetts $4.14B AUM 16.9% 1-Year Est. Return

Tower Research Capital (TRC)'s Q1 2023 Portfolio in Review

As of Q1 2023, Tower Research Capital (TRC) held 6,828 positions worth $3.14B, up 30% from $2.41B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Tower Research Capital (TRC) deployed $534M of net new capital in Q1 2023, opening 511 new positions and adding to 3,030 existing holdings. Its largest new stake was iShares Russell 2000 Growth ETF: 100,561 shares worth $22.8M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $52.8M trimmed.

  • Tower Research Capital (TRC)'s largest Q1 2023 buy was iShares Russell 2000 Growth ETF: 100,561 shares worth $22.8M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q1 2023, an estimated $204M increase.
  • Tower Research Capital (TRC)'s biggest Q1 2023 reduction was iShares Russell 2000 ETF, cutting an estimated $52.8M.
  • Tower Research Capital (TRC) fully exited Myovant Sciences Ltd. in Q1 2023, selling an estimated $7.26M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 38% of its $3.14B portfolio in Q1 2023.
  • Tower Research Capital (TRC) opened 511 new positions and closed 625 in Q1 2023.
  • Tower Research Capital (TRC)'s portfolio value rose 30% quarter-over-quarter to $3.14B.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2023, filed 9 May 2023.